Good morning from the Financial Times. Today is Tuesday, June 8th, and this is your F.T. news briefing.

US officials say they've recovered some of the ransom money paid to colonial pipeline hackers,

American drug regulators greenlight a controversial Alzheimer's treatment,

and Mexico's president loses support in recent elections.

Plus Abu Dhabi is investing billions of dollars into arts and media.

What they're trying to do is double down on this process of broadening the economy away from oil,

and they've identified creative industries as a key aspect of that rise.

I'm Mark Filipino, and here's the news you need to start your day.

Remember last month's hack on the colonial pipeline,

one that disrupted fuel supplies and caused panic buying at gas stations on the US East Coast?

The pipeline company ended up paying a ransom worth nearly four and a half million dollars in Bitcoin.

But yesterday, US officials said they recovered about half of those funds.

They did so after identifying a virtual wallet used by the ransomware hacking group Darkside.

Now it is rare to recover ransom from a cyber hacks since the criminals usually demand payment in anonymous cryptocurrencies.

But the transactions are done on a blockchain, which is like a fixed virtual ledger.

So investigators have a chance to track them.

The US Food and Drug Administration on Monday approved the first new treatment for Alzheimer's disease in almost two decades.

It's called Adu Kenamab. It's made by Biogen, and the company claims the drug slows down the progression of Alzheimer's by breaking up clumps of plaque that form in the brain.

Biogen stock skyrocketed on the news. It was up more than 50% at one point on Monday.

The FT's Niko Azgari explains why investors are so enthusiastic despite continued debate over whether the drug actually works.

In their clinical trials, they trialled the drug on people's mild to moderately severe Alzheimer's.

But the label of the drug says that it's available to treat anyone with Alzheimer's.

...